Type | Public company |
---|---|
LSE: INOV | |
Founded | 2015 |
Website | Official site |
Schroders Capital Global Innovation Trust plc (LSE: INOV), formerly Schroders UK Public Private Trust and before that Woodford Patient Capital Trust, is a British investment trust dedicated to long-term investments predominantly in the United Kingdom.[1][2] The company was established in 2015.[3] It is listed on the London Stock Exchange.[3] The chairman is Susan Searle.[4]
The fund was managed by Woodford Investment Management led by Neil Woodford until December 2019 when the fund came under the management of Schroders.[5][6]
Among other early stage investments, through its portfolio company, Industrial Heat, the trust is the world's largest institutional investor in the pseudoscientific Cold Fusion technology.[7]
The trust changed its name from Woodford Patient Capital Trust to Schroders UK Public Private Trust on 16 December 2019[5] and was renamed to Schroders Capital Global Innovation Trust in April 2023.[8]
References
- ↑ "Change of Name". London Stock Exchange. LSE. Retrieved 25 October 2023.
- ↑ "Schroder UK Public Private rebrands as co-manager Roger Doig steps down". Investment Week. Arc Network - incisivemedia. 17 April 2023. Retrieved 25 October 2023.
- 1 2 "Schroders UK Public Private Trust". London Stock Exchange. Retrieved 12 August 2020.
- ↑ "Woodford Patient Capital unveils plans to reduce debt". FT.com. 28 June 2019. Retrieved 12 August 2020.
- 1 2 "Woodford Patient Capital trust changes name". FT. 16 December 2019.
- ↑ "Woodford Patient Capital and the challenges ahead". Investors Chronicle. 31 October 2019. Retrieved 12 August 2020.
- ↑ "Woodford Patient Capital gets 357% energy boost". Citywire. 21 September 2018. Retrieved 23 September 2018.
- ↑ "INOV is on the next phase of its journey yet the discount still reflects legacy issues…". Trust Intelligence. Retrieved 25 October 2023.
External links